April Issue: Defining the Biology of Estrogen Receptor-Low-Positive #BreastCancer Tessa Higgins Olga Kantor MD, MS, FACS Tari King MD Brigham and Women’s Department of Surgery Harold J. Burstein, MD, PhD, FASCO Sara Tolaney Dana-Farber

rdcu.be/dFeaV

Welcome and congratulations to our Brigham and Women’s Department of Surgery categorical interns 2024-2025!

#AudioVisualAbstract : National Trends in “ #GoingFlat ” After #Mastectomy Amanda L Kong, MD MS Medical College of Wisconsin

rdcu.be/dwamo

Check out this new study defining the biology of estrogen receptor-low-positive #breastcancer recently published in AnnalsSurgOncology from Tessa Higgins Olga Kantor MD, MS, FACS Dr. E Mittendorf Tari King MD #AnaGarridoCastro Harold J. Burstein, MD, PhD, FASCO Stuart Schnitt #OncotypeDX
📄👉pubmed.ncbi.nlm.nih.gov/38161200/

Thank you AnnalsSurgOncology for highlighting our research!

Defining the Biology of ER-Low Positive Breast Cancer

Most ER-low+/HER2- breast cancers are basal-like, with RS ≥26 suggesting these tumors are similar to triple-negative disease

Dana-Farber’s Breast Oncology Center

link.springer.com/article/10.124…

Hi #MedTwitter ! Hoping to connect with future colleagues and mentors ahead of general surgery match 2024 🩺

My interests include preventative medicine and translational research within the field of surgery. Excited to meet you all!

#Match2024 #Surgmatch

Great to connect with friends and learn from so many inspiring speakers at the ASBrS conference! #ASBrS23

Dr. E Mittendorf of Brigham and Women’s Department of Surgery Dana-Farber’s Breast Oncology Center @brighamcancer gives fantastic overview of how to integrate cdk4/6i, COMPASS trial, #pembro , immunotherapy data into surgical care. Node status matters in cT1c Her2+/TNBC, Ax US can be v helpful for nodal staging
#asbrs23

Such a fun night supporting The Breast Cancer Research Foundation with Dana-Farber’s Breast Oncology Center and Brigham and Women’s Department of Surgery !

Excited for another powerhouse grand rounds this week as we welcome Harvard Medical School Distinguished Chair in Surgical Oncology and Brigham and Women's Hospital Vice chair for Research & Surgery, Dr. Elizabeth Mittendorf!

You don’t want to miss this! See you Wednesday 4/12 at 8 am!
#academicsurgery

A low-cost, pragmatic intervention to improve outcomes in early-stage breast cancer

A great joint journal club discussing complex issue in #breastcancer #immunology with powerhouse labs Sandra McAllister Judith Agudo Peter van Galen Dr. E Mittendorf. Only screenshot I got...we are deep in thought! Dana-Farber’s Breast Oncology Center Brigham and Women’s Department of Surgery

Had so much fun attending #SSO2023 ! Thank you to everyone who made my first time so memorable. Hopefully many more to come!

Congratulations Charity Glass !!! #SSO2023 Society of Surgical Oncology

The 2023 AAS Presidential Address - Removing the Mask by @lubitz_carrie is now available for viewing.

Go to the AAS web site (aasurg.org) or view directly on Vimeo and Youtube:

vimeo.com/804101487

youtube.com/watch?v=JaNBH4…

My brother’s engaged and we couldn’t be happier! Welcome to the family 💛

If you haven't yet, VOTE TODAY to support this important project, which will further our understanding of the #RacialDisparities which exist in #BreastCancer outcomes.
Cast your vote here: brightfuturesprize.org #BlackBreastCancer Dr. E Mittendorf
Sandra McAllister Brigham and Women's Hospital

It’s Breast Cancer Awareness Month!Learn more about our project and help us create a BRight Future by voting! Brigham and Women's Hospital Brigham and Women’s Department of Surgery Dr. E Mittendorf Sandra McAllister @OgayoE Dana-Farber’s Breast Oncology Center Sara Tolaney Tari King MD Brigham and Women’s Department of Surgery

Understanding your risk of breast cancer may influence your recommendations for screening. The BPREP program @BWH Dana-Farber’s Breast Oncology Center aims to increase awareness and provide education https:Brighamandwomens.org/surgery/breast…. Tessa Higgins Olga Kantor MD, MS, FACS

Live from DFCI BPREP Fall Forum: patient forums are key in negotiating trust, enriching understanding of health conditions, and providing space for individuals to voice questions and concerns. Excited to tune in! Tari King MD Dana-Farber’s Breast Oncology Center